Progressive myoclonus epilepsy
MONDO:0020074A rare group of disorders characterized by the development of myoclonic and tonic-clonic epileptic seizures associated with progressive degeneration of the nervous system.
Also known as: PME, epilepsy, progressive myoclonic, progressive myoclonic epilepsy, progressive myoclonic epilepsy (disorder) [ambiguous], progressive myoclonus epilepsy, familial progressive myoclonic epilepsy
16 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New drug shows promise for rare energy disorder
Disease control CompletedThis study tested a new drug called OMT-28 in 28 people with primary mitochondrial disease, a condition that affects how cells produce energy. Participants took the drug once daily for 6 months, and researchers measured safety, blood markers of inflammation, and symptoms like fat…
Phase: PHASE2 • Sponsor: Omeicos Therapeutics GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Long-Term safety of mitochondrial drug confirmed in 101 patients
Disease control CompletedThis study looked at the safety of vatiquinone in 101 people with inherited mitochondrial disease who had already taken the drug in a previous study or treatment plan. The goal was to track any side effects until the drug became commercially available or the program ended. Partic…
Phase: PHASE3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Traffic-light labels on menus: do they nudge us to eat better?
Knowledge-focused CompletedThis study tested whether adding Nutri-score labels (A to E ratings) to restaurant menus, alongside calorie information, helps people pick healthier meals. Over 600 adults in Liverpool ordered from a menu with either calorie info alone or calorie info plus Nutri-score labels. Res…
Phase: NA • Sponsor: University of Liverpool • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC